13-110706030-C-T
Variant summary
Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_024537.4(CARS2):c.64G>A(p.Gly22Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000544 in 1,406,926 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G22E) has been classified as Uncertain significance.
Frequency
Consequence
NM_024537.4 missense
Scores
Clinical Significance
Conservation
Publications
- combined oxidative phosphorylation defect type 27Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Laboratory for Molecular Medicine, G2P
- mitochondrial diseaseInheritance: AR Classification: MODERATE Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -16 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00292 AC: 444AN: 151904Hom.: 3 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000245 AC: 12AN: 48956 AF XY: 0.000239 show subpopulations
GnomAD4 exome AF: 0.000255 AC: 320AN: 1254914Hom.: 2 Cov.: 31 AF XY: 0.000206 AC XY: 127AN XY: 616874 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00293 AC: 445AN: 152012Hom.: 3 Cov.: 32 AF XY: 0.00293 AC XY: 218AN XY: 74332 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Benign:2
- -
- -
Combined oxidative phosphorylation defect type 27 Benign:1
- -
Inborn genetic diseases Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
CARS2-related disorder Benign:1
This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at